| Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More | Alex Lash | 02/10/17 | National |
| Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins | Ben Fidler | 02/03/17 | National |
| Insurer UHC Will Cover Biogen Spine Drug, But With Limits And Proof | Ben Fidler | 02/02/17 | Boston |
| Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths | Ben Fidler | 02/01/17 | Boston |
| Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More | Ben Fidler | 01/27/17 | National |
| Anthem Caps Coverage Of Biogen Spine Drug Despite Wide FDA Approval | Ben Fidler | 01/24/17 | Boston |
| Families Fret As Insurers Mull Biogen’s $750K Spine Disease Drug | Ben Fidler | 01/06/17 | National |
| Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More | Ben Fidler | 11/11/16 | National |
| New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease | Ben Fidler | 11/07/16 | Boston |
